--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
D.R. Horton
DHI
Taylor Morrison Home
TMHC
Apple
AAPL
Toll Brothers
TOL
Lennar Corp
LEN
US Stock MarketDetailed Quotes
ELEV Elevation Oncology
- 0.499
- -0.027-5.06%
Trading Mar 18 09:59 ET
29.57MMarket Cap-0.64P/E (TTM)
0.520High0.489Low80.53KVolume0.520Open0.526Pre Close40.35KTurnover0.19%Turnover RatioLossP/E (Static)59.22MShares5.83052wk High0.49P/B21.43MFloat Cap0.41552wk Low--Dividend TTM42.92MShs Float16.220Historical High--Div YieldTTM5.93%Amplitude0.363Historical Low0.501Avg Price1Lot Size
Elevation Oncology Key Stats
Elevation Oncology Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Elevation Oncology Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data